ingest
cdrApp
2018-06-13T15:18:43.711Z
51cd2fe2-3fd7-401f-a923-a97bc3db68a2
modifyDatastreamByValue
RELS-EXT
fedoraAdmin
2018-06-13T15:45:11.703Z
Setting exclusive relation
addDatastream
MD_TECHNICAL
fedoraAdmin
2018-06-13T15:45:12.334Z
Adding technical metadata derived by FITS
addDatastream
MD_FULL_TEXT
fedoraAdmin
2018-06-13T15:45:24.402Z
Adding full text metadata extracted by Apache Tika
modifyDatastreamByValue
RELS-EXT
fedoraAdmin
2018-06-13T15:45:46.955Z
Setting exclusive relation
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-07-16T21:29:02.851Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-07-18T17:03:01.915Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-08-22T15:45:32.692Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-09-28T18:33:05.733Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-10-12T17:23:30.839Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2019-03-22T20:45:28.606Z
James
Byrnes
Author
Department of Pathology and Laboratory Medicine
School of Medicine
Defining the Interactions Between Coagulation Factor XIII, Fibrin(ogen), and Red Blood Cells
Blood coagulation is the process where a cascade of enzymatic reactions generates a clot to stem the flow of blood following injury. Unfortunately, the same cascade can also form pathologic intravenous clots in a process termed venous thrombosis. Current anticoagulant therapies used to prevent thrombosis also carry a risk of bleeding. Further investigation of the basic biochemical and regulatory mechanisms underlying coagulation are required to identify new antithrombotic strategies with reduced risk of bleeding. The studies presented in this dissertation examine the interactions between three key players in the terminal stages of blood coagulation: factor XIII (FXIII), fibrin(ogen), and red blood cells (RBCs).
First, we examined the mechanism of FXIII-mediated RBC retention in clots. We found that FXIII does not promote RBC retention by crosslinking RBCs directly to the clot or by modulating fibrin network density. Instead, specific FXIII-mediated crosslinking of the fibrin α-chains is required for normal RBC retention in clots. This finding is the first to reveal a pathophysiologic role of α-chain crosslinking, and establishes this process as a crucial mediator of venous thrombosis.
Second, we investigated the nature of the FXIII-fibrinogen binding interaction to determine the domains of each protein involved in binding. We found that FXIII binds to fibrinogen γ-chain residues 390-396 via the FXIII-B subunits. These findings enhance our understanding of this important interaction in both physiologic and pathologic coagulation.
Third, we examined the regulation of the FXIII-A and -B subunits. We found that the FXIII subunits exhibit inter-tissue, reciprocal regulation whereby FXIII-B promotes FXIII-A stability in circulation, while FXIII-A increases FXIII-B stability and production. FXIII-A upregulates liver RNA-binding proteins and may modulate post-transcriptional regulation of FXIII-B synthesis. These data clarify the mechanisms governing FXIII levels in plasma and identify a unique regulatory relationship between two protein subunits synthesized in different tissues. These data also expose a new liver-regulatory function of FXIII-A.
Collectively, these studies greatly extend our understanding of the interactions between FXIII, fibrin(ogen), and RBCs, three crucial mediators of clot dynamics. Importantly, this dissertation also emphasizes the utility of basic mechanistic studies to inform translational research efforts.
Spring 2018
2018
Biochemistry
Biophysics
Biology
Clot, Clotting, Crosslinking, Fibrin, Protein-Protein Interactions, Thrombosis
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Pathology
Alisa
Wolberg
Thesis advisor
Dorothy
Erie
Thesis advisor
Nigel
Key
Thesis advisor
Nigel
Mackman
Thesis advisor
Dougald
Monroe
Thesis advisor
David
Williams
Thesis advisor
text
James
Byrnes
Author
Department of Pathology and Laboratory Medicine
School of Medicine
Defining the Interactions Between Coagulation Factor XIII, Fibrin(ogen), and Red Blood Cells
Blood coagulation is the process where a cascade of enzymatic reactions generates a clot to stem the flow of blood following injury. Unfortunately, the same cascade can also form pathologic intravenous clots in a process termed venous thrombosis. Current anticoagulant therapies used to prevent thrombosis also carry a risk of bleeding. Further investigation of the basic biochemical and regulatory mechanisms underlying coagulation are required to identify new antithrombotic strategies with reduced risk of bleeding. The studies presented in this dissertation examine the interactions between three key players in the terminal stages of blood coagulation: factor XIII (FXIII), fibrin(ogen), and red blood cells (RBCs).
First, we examined the mechanism of FXIII-mediated RBC retention in clots. We found that FXIII does not promote RBC retention by crosslinking RBCs directly to the clot or by modulating fibrin network density. Instead, specific FXIII-mediated crosslinking of the fibrin α-chains is required for normal RBC retention in clots. This finding is the first to reveal a pathophysiologic role of α-chain crosslinking, and establishes this process as a crucial mediator of venous thrombosis.
Second, we investigated the nature of the FXIII-fibrinogen binding interaction to determine the domains of each protein involved in binding. We found that FXIII binds to fibrinogen γ-chain residues 390-396 via the FXIII-B subunits. These findings enhance our understanding of this important interaction in both physiologic and pathologic coagulation.
Third, we examined the regulation of the FXIII-A and -B subunits. We found that the FXIII subunits exhibit inter-tissue, reciprocal regulation whereby FXIII-B promotes FXIII-A stability in circulation, while FXIII-A increases FXIII-B stability and production. FXIII-A upregulates liver RNA-binding proteins and may modulate post-transcriptional regulation of FXIII-B synthesis. These data clarify the mechanisms governing FXIII levels in plasma and identify a unique regulatory relationship between two protein subunits synthesized in different tissues. These data also expose a new liver-regulatory function of FXIII-A.
Collectively, these studies greatly extend our understanding of the interactions between FXIII, fibrin(ogen), and RBCs, three crucial mediators of clot dynamics. Importantly, this dissertation also emphasizes the utility of basic mechanistic studies to inform translational research efforts.
Spring 2018
2018
Biochemistry
Biophysics
Biology
Clot, Clotting, Crosslinking, Fibrin, Protein-Protein Interactions, Thrombosis
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Pathology
Alisa
Wolberg
Thesis advisor
Dorothy
Erie
Thesis advisor
Nigel
Key
Thesis advisor
Nigel
Mackman
Thesis advisor
Dougald
Monroe
Thesis advisor
David
Williams
Thesis advisor
text
James
Byrnes
Author
Department of Pathology and Laboratory Medicine
School of Medicine
Defining the Interactions Between Coagulation Factor XIII, Fibrin(ogen), and Red Blood Cells
Blood coagulation is the process where a cascade of enzymatic reactions generates a clot to stem the flow of blood following injury. Unfortunately, the same cascade can also form pathologic intravenous clots in a process termed venous thrombosis. Current anticoagulant therapies used to prevent thrombosis also carry a risk of bleeding. Further investigation of the basic biochemical and regulatory mechanisms underlying coagulation are required to identify new antithrombotic strategies with reduced risk of bleeding. The studies presented in this dissertation examine the interactions between three key players in the terminal stages of blood coagulation: factor XIII (FXIII), fibrin(ogen), and red blood cells (RBCs).
First, we examined the mechanism of FXIII-mediated RBC retention in clots. We found that FXIII does not promote RBC retention by crosslinking RBCs directly to the clot or by modulating fibrin network density. Instead, specific FXIII-mediated crosslinking of the fibrin α-chains is required for normal RBC retention in clots. This finding is the first to reveal a pathophysiologic role of α-chain crosslinking, and establishes this process as a crucial mediator of venous thrombosis.
Second, we investigated the nature of the FXIII-fibrinogen binding interaction to determine the domains of each protein involved in binding. We found that FXIII binds to fibrinogen γ-chain residues 390-396 via the FXIII-B subunits. These findings enhance our understanding of this important interaction in both physiologic and pathologic coagulation.
Third, we examined the regulation of the FXIII-A and -B subunits. We found that the FXIII subunits exhibit inter-tissue, reciprocal regulation whereby FXIII-B promotes FXIII-A stability in circulation, while FXIII-A increases FXIII-B stability and production. FXIII-A upregulates liver RNA-binding proteins and may modulate post-transcriptional regulation of FXIII-B synthesis. These data clarify the mechanisms governing FXIII levels in plasma and identify a unique regulatory relationship between two protein subunits synthesized in different tissues. These data also expose a new liver-regulatory function of FXIII-A.
Collectively, these studies greatly extend our understanding of the interactions between FXIII, fibrin(ogen), and RBCs, three crucial mediators of clot dynamics. Importantly, this dissertation also emphasizes the utility of basic mechanistic studies to inform translational research efforts.
Spring 2018
2018
Biochemistry
Biophysics
Biology
Clot, Clotting, Crosslinking, Fibrin, Protein-Protein Interactions, Thrombosis
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Pathology
Alisa
Wolberg
Thesis advisor
Dorothy
Erie
Thesis advisor
Nigel
Key
Thesis advisor
Nigel
Mackman
Thesis advisor
Dougald
Monroe
Thesis advisor
David
Williams
Thesis advisor
text
James
Byrnes
Author
Department of Pathology and Laboratory Medicine
School of Medicine
Defining the Interactions Between Coagulation Factor XIII, Fibrin(ogen), and Red Blood Cells
Blood coagulation is the process where a cascade of enzymatic reactions generates a clot to stem the flow of blood following injury. Unfortunately, the same cascade can also form pathologic intravenous clots in a process termed venous thrombosis. Current anticoagulant therapies used to prevent thrombosis also carry a risk of bleeding. Further investigation of the basic biochemical and regulatory mechanisms underlying coagulation are required to identify new antithrombotic strategies with reduced risk of bleeding. The studies presented in this dissertation examine the interactions between three key players in the terminal stages of blood coagulation: factor XIII (FXIII), fibrin(ogen), and red blood cells (RBCs).
First, we examined the mechanism of FXIII-mediated RBC retention in clots. We found that FXIII does not promote RBC retention by crosslinking RBCs directly to the clot or by modulating fibrin network density. Instead, specific FXIII-mediated crosslinking of the fibrin α-chains is required for normal RBC retention in clots. This finding is the first to reveal a pathophysiologic role of α-chain crosslinking, and establishes this process as a crucial mediator of venous thrombosis.
Second, we investigated the nature of the FXIII-fibrinogen binding interaction to determine the domains of each protein involved in binding. We found that FXIII binds to fibrinogen γ-chain residues 390-396 via the FXIII-B subunits. These findings enhance our understanding of this important interaction in both physiologic and pathologic coagulation.
Third, we examined the regulation of the FXIII-A and -B subunits. We found that the FXIII subunits exhibit inter-tissue, reciprocal regulation whereby FXIII-B promotes FXIII-A stability in circulation, while FXIII-A increases FXIII-B stability and production. FXIII-A upregulates liver RNA-binding proteins and may modulate post-transcriptional regulation of FXIII-B synthesis. These data clarify the mechanisms governing FXIII levels in plasma and identify a unique regulatory relationship between two protein subunits synthesized in different tissues. These data also expose a new liver-regulatory function of FXIII-A.
Collectively, these studies greatly extend our understanding of the interactions between FXIII, fibrin(ogen), and RBCs, three crucial mediators of clot dynamics. Importantly, this dissertation also emphasizes the utility of basic mechanistic studies to inform translational research efforts.
Spring 2018
2018
Biochemistry
Biophysics
Biology
Clot, Clotting, Crosslinking, Fibrin, Protein-Protein Interactions, Thrombosis
eng
Doctor of Philosophy
Dissertation
Pathology
Alisa
Wolberg
Thesis advisor
Dorothy
Erie
Thesis advisor
Nigel
Key
Thesis advisor
Nigel
Mackman
Thesis advisor
Dougald
Monroe
Thesis advisor
David
Williams
Thesis advisor
text
University of North Carolina at Chapel Hill
Degree granting institution
James
Byrnes
Creator
Department of Pathology and Laboratory Medicine
School of Medicine
Defining the Interactions Between Coagulation Factor XIII, Fibrin(ogen), and Red Blood Cells
Blood coagulation is the process where a cascade of enzymatic reactions generates a clot to stem the flow of blood following injury. Unfortunately, the same cascade can also form pathologic intravenous clots in a process termed venous thrombosis. Current anticoagulant therapies used to prevent thrombosis also carry a risk of bleeding. Further investigation of the basic biochemical and regulatory mechanisms underlying coagulation are required to identify new antithrombotic strategies with reduced risk of bleeding. The studies presented in this dissertation examine the interactions between three key players in the terminal stages of blood coagulation: factor XIII (FXIII), fibrin(ogen), and red blood cells (RBCs).
First, we examined the mechanism of FXIII-mediated RBC retention in clots. We found that FXIII does not promote RBC retention by crosslinking RBCs directly to the clot or by modulating fibrin network density. Instead, specific FXIII-mediated crosslinking of the fibrin α-chains is required for normal RBC retention in clots. This finding is the first to reveal a pathophysiologic role of α-chain crosslinking, and establishes this process as a crucial mediator of venous thrombosis.
Second, we investigated the nature of the FXIII-fibrinogen binding interaction to determine the domains of each protein involved in binding. We found that FXIII binds to fibrinogen γ-chain residues 390-396 via the FXIII-B subunits. These findings enhance our understanding of this important interaction in both physiologic and pathologic coagulation.
Third, we examined the regulation of the FXIII-A and -B subunits. We found that the FXIII subunits exhibit inter-tissue, reciprocal regulation whereby FXIII-B promotes FXIII-A stability in circulation, while FXIII-A increases FXIII-B stability and production. FXIII-A upregulates liver RNA-binding proteins and may modulate post-transcriptional regulation of FXIII-B synthesis. These data clarify the mechanisms governing FXIII levels in plasma and identify a unique regulatory relationship between two protein subunits synthesized in different tissues. These data also expose a new liver-regulatory function of FXIII-A.
Collectively, these studies greatly extend our understanding of the interactions between FXIII, fibrin(ogen), and RBCs, three crucial mediators of clot dynamics. Importantly, this dissertation also emphasizes the utility of basic mechanistic studies to inform translational research efforts.
Biochemistry
Biophysics
Biology
Clot; Clotting; Crosslinking; Fibrin; Protein-Protein Interactions; Thrombosis
eng
Doctor of Philosophy
Dissertation
Pathology
Alisa
Wolberg
Thesis advisor
Dorothy
Erie
Thesis advisor
Nigel
Key
Thesis advisor
Nigel
Mackman
Thesis advisor
Dougald
Monroe
Thesis advisor
David
Williams
Thesis advisor
text
University of North Carolina at Chapel Hill
Degree granting institution
2018
2018-05
James
Byrnes
Author
Department of Pathology and Laboratory Medicine
School of Medicine
Defining the Interactions Between Coagulation Factor XIII, Fibrin(ogen), and Red Blood Cells
Blood coagulation is the process where a cascade of enzymatic reactions generates a clot to stem the flow of blood following injury. Unfortunately, the same cascade can also form pathologic intravenous clots in a process termed venous thrombosis. Current anticoagulant therapies used to prevent thrombosis also carry a risk of bleeding. Further investigation of the basic biochemical and regulatory mechanisms underlying coagulation are required to identify new antithrombotic strategies with reduced risk of bleeding. The studies presented in this dissertation examine the interactions between three key players in the terminal stages of blood coagulation: factor XIII (FXIII), fibrin(ogen), and red blood cells (RBCs).
First, we examined the mechanism of FXIII-mediated RBC retention in clots. We found that FXIII does not promote RBC retention by crosslinking RBCs directly to the clot or by modulating fibrin network density. Instead, specific FXIII-mediated crosslinking of the fibrin α-chains is required for normal RBC retention in clots. This finding is the first to reveal a pathophysiologic role of α-chain crosslinking, and establishes this process as a crucial mediator of venous thrombosis.
Second, we investigated the nature of the FXIII-fibrinogen binding interaction to determine the domains of each protein involved in binding. We found that FXIII binds to fibrinogen γ-chain residues 390-396 via the FXIII-B subunits. These findings enhance our understanding of this important interaction in both physiologic and pathologic coagulation.
Third, we examined the regulation of the FXIII-A and -B subunits. We found that the FXIII subunits exhibit inter-tissue, reciprocal regulation whereby FXIII-B promotes FXIII-A stability in circulation, while FXIII-A increases FXIII-B stability and production. FXIII-A upregulates liver RNA-binding proteins and may modulate post-transcriptional regulation of FXIII-B synthesis. These data clarify the mechanisms governing FXIII levels in plasma and identify a unique regulatory relationship between two protein subunits synthesized in different tissues. These data also expose a new liver-regulatory function of FXIII-A.
Collectively, these studies greatly extend our understanding of the interactions between FXIII, fibrin(ogen), and RBCs, three crucial mediators of clot dynamics. Importantly, this dissertation also emphasizes the utility of basic mechanistic studies to inform translational research efforts.
Spring 2018
2018
Biochemistry
Biophysics
Biology
Clot, Clotting, Crosslinking, Fibrin, Protein-Protein Interactions, Thrombosis
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Pathology
Alisa
Wolberg
Thesis advisor
Dorothy
Erie
Thesis advisor
Nigel
Key
Thesis advisor
Nigel
Mackman
Thesis advisor
Dougald
Monroe
Thesis advisor
David
Williams
Thesis advisor
text
James
Byrnes
Creator
Department of Pathology and Laboratory Medicine
School of Medicine
Defining the Interactions Between Coagulation Factor XIII, Fibrin(ogen), and Red Blood Cells
Blood coagulation is the process where a cascade of enzymatic reactions generates a clot to stem the flow of blood following injury. Unfortunately, the same cascade can also form pathologic intravenous clots in a process termed venous thrombosis. Current anticoagulant therapies used to prevent thrombosis also carry a risk of bleeding. Further investigation of the basic biochemical and regulatory mechanisms underlying coagulation are required to identify new antithrombotic strategies with reduced risk of bleeding. The studies presented in this dissertation examine the interactions between three key players in the terminal stages of blood coagulation: factor XIII (FXIII), fibrin(ogen), and red blood cells (RBCs).
First, we examined the mechanism of FXIII-mediated RBC retention in clots. We found that FXIII does not promote RBC retention by crosslinking RBCs directly to the clot or by modulating fibrin network density. Instead, specific FXIII-mediated crosslinking of the fibrin α-chains is required for normal RBC retention in clots. This finding is the first to reveal a pathophysiologic role of α-chain crosslinking, and establishes this process as a crucial mediator of venous thrombosis.
Second, we investigated the nature of the FXIII-fibrinogen binding interaction to determine the domains of each protein involved in binding. We found that FXIII binds to fibrinogen γ-chain residues 390-396 via the FXIII-B subunits. These findings enhance our understanding of this important interaction in both physiologic and pathologic coagulation.
Third, we examined the regulation of the FXIII-A and -B subunits. We found that the FXIII subunits exhibit inter-tissue, reciprocal regulation whereby FXIII-B promotes FXIII-A stability in circulation, while FXIII-A increases FXIII-B stability and production. FXIII-A upregulates liver RNA-binding proteins and may modulate post-transcriptional regulation of FXIII-B synthesis. These data clarify the mechanisms governing FXIII levels in plasma and identify a unique regulatory relationship between two protein subunits synthesized in different tissues. These data also expose a new liver-regulatory function of FXIII-A.
Collectively, these studies greatly extend our understanding of the interactions between FXIII, fibrin(ogen), and RBCs, three crucial mediators of clot dynamics. Importantly, this dissertation also emphasizes the utility of basic mechanistic studies to inform translational research efforts.
2018-05
2018
Biochemistry
Biophysics
Biology
Clot; Clotting; Crosslinking; Fibrin; Protein-Protein Interactions; Thrombosis
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Alisa
Wolberg
Thesis advisor
Dorothy
Erie
Thesis advisor
Nigel
Key
Thesis advisor
Nigel
Mackman
Thesis advisor
Dougald
Monroe
Thesis advisor
David
Williams
Thesis advisor
text
Byrnes_unc_0153D_17773.pdf
uuid:365ddfa5-f957-4b9b-bfc0-d08c0a3cac24
2020-06-13T00:00:00
2018-04-18T20:35:24Z
proquest
application/pdf
43789018